Dr. Ahmet Hoke focuses on neuromuscular diseases with a particular interest in peripheral nerve diseases. He has specialized expertise in nerve conduction studies, electromyography and nerve and muscle biopsy reading. In 2005, he received the coveted Derek Denny Brown Young Neurological Scholar Award given by the American Neurological Association to a member of the association who has achieved a significant stature in neurological research and whose promise of continuing major contributions to the field of neurology is anticipated.

In 2018, Dr. Hoke received the Wolfe Neuropathy Research Prize for the preclinical development of the drug ethoxyquin (EQ-6) for neuroprotection against chemotherapy-induced peripheral neuropathy. The prize was given by the American Neurological Association.

Dr. Ahmet Hoke received his medical degree from Hacettepe University in Ankara, Turkey. He then completed an internship and residency in medicine at MetroHealth Saint Lukes Medical Center in Cleveland, OH. He completed his Ph.D. in Neuroscience at Case Western Reserve University before joining The Johns Hopkins for his neurology residency. He went on to the University of Calgary for a neuromuscular fellowship.